DATED: 30 April 2008 Shareholders’ Agreement between Mr Lin Shuipan, Richwise International Investment Group Limited, Tiancheng Int’l Investment Group Limited, HK Haima Group Limited and Eagle Rise Investments Limited as Ordinary Shareholders and...
DATED: 30
April 2008
between
Xx Xxx
Shuipan, Richwise International Investment Group Limited, Tiancheng Int’l
Investment Group Limited, XX Xxxxx Group Limited and Eagle Rise Investments
Limited
as
Ordinary Shareholders
and
Elevatech
Limited
as
Investor
and
Xdlong
International Company Limited
as
the Company
relating
to
Xdlong
International Company Limited

CONTENTS
1.
|
Interpretation
|
2
|
2.
|
Directors
and Management
|
6
|
3.
|
Shareholder
Meetings
|
8
|
4.
|
Information
|
9
|
5.
|
Reserved
Matters
|
10
|
6.
|
Pre-emption
on issues of New Securities
|
10
|
7.
|
Pre-emptions
on transfers of Shares
|
11
|
8.
|
Tag-along
|
12
|
9.
|
Qualified
IPO
|
13
|
10.
|
Rights
during Listing Process
|
14
|
11.
|
Registration
rights
|
15
|
12.
|
Representations
and Warranties of the Xxxxxxxxxxxx
|
00
|
00.
|
FCPA
warranty and undertaking
|
16
|
14.
|
Tax
matters
|
16
|
15.
|
Adherence
and Assignment
|
17
|
16.
|
Announcement
|
18
|
17.
|
Compliance
|
18
|
18.
|
Confidentiality
|
18
|
19.
|
Supremacy
|
20
|
20.
|
Termination
|
20
|
21.
|
General
|
20
|
22.
|
Waiver
|
21
|
23.
|
Notices
|
21
|
24.
|
Information
to Investor
|
22
|
25.
|
Law
and Jurisdiction
|
22
|
SCHEDULE
1
|
|
|
PART
1 : THE INVESTOR
|
|
|
PART
2 : THE ORDINARY SHAREHOLDERS
|
|
|
SCHEDULE
2 : FORM OF DEED OF ADHERENCE
|
|
|
SCHEDULE
3 : RESERVED MATTERS
|
|
|
SCHEDULE
4 : ARTICLES OF THE COMPANY
|
|
THIS
AGREEMENT is
dated 30 April 2008 and made
BETWEEN:
(1)
|
XDLONG
INTERNATIONAL COMPANY LIMITED (“Company”), a company incorporated in the Cayman
Islands having company number CT-207339 and having its registered office
at Cricket Square, Xxxxxxxx Drive, P.O. Box 2681, Grand Cayman, KY1-1111,
Cayman Islands;
|
(2)
|
ELEVATECH
LIMITED (“Investor”) a company
incorporated in Hong Kong and having its registered office at 68th
Floor, Xxxxxx Kong Center, 0 Xxxxx’x Xxxx Xxxxxxx, Xxxx Xxxx;
and
|
(3)
|
THE
PERSONS whose names and
addresses are set out in Part 2 of schedule 1 (the “Ordinary
Shareholders” and each an “Ordinary
Shareholder”).
|
WHEREAS:
This
Agreement contains the terms upon which the Investor and the Ordinary
Shareholders have agreed to regulate the affairs of the Company and the
relationship between the Shareholders of the Company.
IT IS
AGREED as follows:
1.
|
Interpretation
|
1.1
|
Definitions
|
In this
Agreement:
“Acting in
Concert” bears the meaning given to
it in the Hong Kong Codes on Takeovers and Mergers and Share
Repurchases;
“Adjustment Event” has the meaning given to it in the Share
Purchase Agreement;
“Articles” means the Company’s amended and restated
articles of association adopted on the date of this Agreement and set out in
schedule 4 and thereafter as amended from time to time in accordance with this
Agreement (and Article shall be construed accordingly);
“Board” means the board of Directors of the
Company;
“Business Day” means a day other than Saturday or Sunday, on
which banks are open for ordinary banking business in Hong Kong;
“Confidential
Information” means all information (including this Agreement) that is
confidential and which is (i) provided by the Investor or the Shareholders or
(ii) used in or otherwise relates to the business, customers, suppliers,
financial, technical or other affairs of any member of the Group including,
without limitation, information relating to:
(A)
|
the
preparation, negotiation or discussions relating to the investment in the
Company by the Investor or execution of this Agreement or matters
ancillary thereto;
|
(B)
|
the
marketing of goods or services including, without limitation, customer
names and lists and other details of customers, sales targets, sales
statistics, market share statistics, discount rates, prices, market
research reports and surveys and advertising or other promotional
materials; and
|
2
(C)
|
future
projects, business development or planning, commercial relationships and
negotiations;
|
(D)
|
information
that has been supplied to any member of the Group in confidence;
or
|
(E)
|
matters
in respect of which any member of the Group is bound by an obligation of
confidence to a third party,
|
that is
disclosed (whether in writing, verbally or by any other means and whether
directly or indirectly) by one party (the “Disclosing Party”) to
any other party (the “Receiving Party”)
whether before or after the date of this Agreement;
“Control” when used
with respect to any specified person means ownership of more than 50 per cent.
of the voting shares capital or equivalent right of ownership of such company or
entity, or power to direct its policies and management. The terms “Controlling”, “Controlling” Interest
and “Controlled” have
meanings correlative to the foregoing;
“Deed of Adherence”
means a deed, substantially in the form set out in schedule 2;
“Directors” means the
Directors of the Company in office for the time being;
“Disclosing Party” has
the meaning given within the definition of Confidential
Information;
“Fully Diluted” means
calculated on the assumption that all Shares then capable of being issued on the
exercise of all conversion rights, option, warrants and other contractual rights
have been issued, irrespective of whether or not such rights are then
exercisable;
“Group” means the
Company and its Subsidiaries from time to time;
“Group Company” means
the Company or any Subsidiary from time to time;
“IFRS” means the
International Financial Reporting Standards as in effect from time to time,
consistently applied during the periods involved;
“Initial Valuation”
has the meaning given to it in the Share Purchase Agreement;
“Investor Director”
means the Director appointed by the Investor pursuant to clause 2.2(A) or his or
her alternate from time to time;
“IPO” means an initial
public offering and listing of Ordinary Shares on a Stock Exchange, including a
Qualified IPO;
“IRR” means the
internal rate of return;
“Laws” mean any
treaty, statute, directive, regulation, decision, order, instrument, by-law, or
any other law of, or having effect in, any jurisdiction;
“Listing Process”
shall mean the process of undertaking an application to any Stock Exchange for
the listing of and permission to deal in Shares on such Stock
Exchange;
3
“New Securities” means
any Shares or other securities convertible into, or carrying the right to
subscribe for Shares, issued by the Company, after the date of this
Agreement;
“Ordinary Shares”
means the Ordinary Shares of HK$0.10 each in the share capital of the Company,
the rights and restrictions attached to which are set out in the
Articles;
“parties” means the
parties to this Agreement together with such persons as become bound by the
terms of this Agreement pursuant to a Deed of Adherence from time to time (and
“party” shall be construed accordingly);
“Performance Adjusted Per
Share Price” has the meaning ascribed to it in schedule 4 of the Share
Purchase Agreement;
“Preferred Shares”
means the convertible redeemable preference shares of HK$0.1 each in the
Company, the terms of which are set out in the Articles;
“Qualified IPO” has
the meaning given to that term in the Share Purchase Agreement;
“RMB” means Renminbi,
the lawful currency of the People’s Republic of China;
“Receiving Party” has
the meaning given within the definition of Confidential
information;
“Reserved Matters”
means those matters set out in schedule 3;
“Selling Shareholders”
means Xx Xxx Shuipan and Richwise International Investment Group
Limited.
“Shares” means
Ordinary Shares and/or Preferred Shares, as appropriate;
“Share Purchase
Agreement” means the agreement dated 28 March 2008 entered into between
the Selling Shareholders, the Company, Xx Xxx Jinlei and the Investor relating
to the acquisition of 5.5 per cent. of the issued share capital of the Company
as enlarged as a result of completion of the Subscription;
“Share Sale” means the
sale of (or the grant of a right to acquire or to dispose of) any of the Shares
(in one transaction or as a series of transactions) which will result in a bona
fide third party purchaser of such Shares (or grantee of such right) and persons
Acting in Concert with him (if any) together acquiring a Controlling Interest in
the Company, save where following completion of such sale the shareholders in
such purchaser and the proportion of shares held by each in such purchaser are
the same as the Shareholders and their Shareholdings in the Company immediately
prior to such sale;
“Shareholder” means
any person who holds any Ordinary Shares or Preferred Shares; and “Ordinary Shareholder” and “Preferred Shareholder” shall be
construed accordingly;
“Stock Exchange” means
any reputable international stock exchange to which the Company submits its
listing application, including but not limited to The Stock Exchange of Hong
Kong Limited;
“Subscription” means
the subscription by the Investor of 2,500 Preferred Shares representing 2.5 per
cent. of the issued share capital of the Company as enlarged as a result of
completion of the Subscription;
“Subscription
Agreement” means the agreement dated 28 March 2008 entered into between
the Investor, the Company and Xx Xxx Shuipan in relation to the
Subscription;
4
“Subsidiary” has the meaning ascribed to it in the
Articles;
“Tax” means any liability of any member of or all of
the Group to any form of taxation (including those of a provisional nature)
whenever created or imposed and whether created or imposed in the British Virgin
Islands, the Cayman Islands, Hong Kong, the PRC or of any other part of the
world and without prejudice to the generality of the foregoing includes profits
tax, provisional profits tax, interest tax, income tax, enterprise income tax,
local income tax, business tax, value added tax, salaries tax, property tax,
estate duty, death duty, capital duty, stamp duty, payroll tax, withholding tax,
rates, customs and exercise duties and generally any tax, duty, impost, levy or
rate or any amount payable to the revenue, customs, fiscal or other authorities
whether of British Virgin Islands, the Cayman Islands, Hong Kong, the PRC or of
any other part of the world and all interest, penalties, claim, damages, fines,
costs, charges, public censure imposed by any authority and expenses incidental
or relating to such Tax; and
“in writing” or “written” means written, printed, typewritten,
lithographed or wholly expressed in any other mode representing or reproducing
words, or partly one and partly another.
1.2 Construction of certain
references
In this
Agreement, where the context admits:
(A)
|
references
to clauses and schedules are references to clauses of and schedules to
this Agreement, references to paragraphs are, unless otherwise stated,
references to paragraphs of the schedule in which the reference appears,
and references to this Agreement include the
schedules;
|
(B)
|
references
to the singular shall include the plural and vice versa and references to
any gender shall include all
genders;
|
(C)
|
“person”
includes any individual, partnership, body corporate, corporation sole or
aggregate, state or agency of a state, and any unincorporated association
or organisation, in each case whether or not having separate legal
personality;
|
(D)
|
“company”
includes any body corporate;
|
(E)
|
references
to the Shareholders include a reference to each of them;
and
|
(F)
|
references
to, or to any provision of, any Laws shall be construed also as references
to all other Laws made under the Law referred to, and to all such Laws as
for the time being amended, re-enacted (with or without amendment),
consolidated or replaced or as their application is modified by other Laws
from time to time.
|
1.3 Headings
The
headings and sub-headings are inserted for convenience only and shall not affect
the construction of this Agreement.
1.4 Schedules
Each of
the schedules shall have effect as if set out herein.
5
2.
Directors
and Management
2.1 Role of the Board
The
parties shall procure that the Board shall
be
responsible for the overall direction, supervision and management
of the Group, provided that the Board shall not take any decision in relation to
any of the Reserved Matters save as in the manner set out in clause
5.
2.2 Investor Director
The
parties shall procure that the Investor shall have the right (but not the
obligation):
(A)
|
to
appoint and maintain in office such natural person as the Investor may
from time to time nominate as a
Director (“Investor
Director”) (and as a
member of each and every committee of the Board) and to
remove any Director so appointed and, upon his removal whether by the
Investor or otherwise to appoint another Director in his place;
or
|
(B)
|
to appoint a
representative to attend at each and any meeting of the
Board and each and any committee of the Board who will be entitled to
speak at any such meeting but will not
vote.
|
2.3 Appointment and
removal
The
appointment and removal of any Investor Director pursuant to clause 2.2(A) or
any representative pursuant to clause 2.2(B) shall be by written notice from the
Investor to the Company and shall take effect upon delivery of written notice at
the Company’s registered office or at any meeting of the Board or any committee
of the Board. The Shareholders undertake to exercise their voting rights in the
Company accordingly to ensure that any person nominated by the Investor to act
as the Investor Director is duly appointed (if any).
2.4 Rights of
representative
Any
representative appointed pursuant to clause 2.2(B) shall have the same rights as
the Investor Director and members of the relevant committee, as applicable, to
receive notice of meetings.
2.5 Notice of meeting
The
Company shall send to the Investor and to any Investor Director or any
representative appointed under clause 2.2(B) (in electronic form if so
required):
(A)
|
reasonable
advance notice of each meeting of the Board (being not less than 7
Business Days, unless all the Directors consent to shorter notice) and
each committee of the Board;
and
|
(B)
|
as
soon as practicable after each meeting of the Board (or committee of the
Board) a copy of the minutes.
|
2.6 Participation in meetings by
telephone
Directors
may participate in any meeting of the Board by means of telephone, electronic or
other communication facilities as permit all persons participating in the
meeting to communicate with each other simultaneously and instantaneously, and
participation in such meeting shall constitute presence in person at such
meeting.
6
2.7
Information
The
Investor Director shall be entitled to report to the Investor on all aspects of
the affairs of the Group and to disclose to the Investor such information
concerning the Group as he shall, in his absolute discretion, reasonably
consider appropriate and/or as the Investor shall from time to time reasonably
require.
2.8 Fees and expenses
(A)
|
The
Company will reimburse all members of the Board for their reasonable
out-of-pocket expenses incurred in connection with their attendance at
Board meetings.
|
(B)
|
The
parties agree that any independent Directors shall be entitled to
customary director’s fees at such times and in such amounts as determined
by the Board.
|
2.9 Composition of
Board
In the
event of a Qualified IPO being contemplated, the Board shall consider, following
consultation with the Investor and the professional advisers engaged by the
Company in relation to the Qualified IPO, changing the composition of the Board
so that its composition is suitable for a public listed company in the
circumstances then contemplated (including, for example, increasing the number
of independent Directors on the Board).
2.10 Share qualification and
alternates
(A)
|
The
Directors shall not be required to hold any share qualification nor shall
they be subject to retirement by
rotation.
|
(B)
|
Each
Director shall be entitled to appoint an alternate to act on his behalf as
a Director, and the Company’s obligations hereunder to each Director and
his respective appointor shall be taken to extend to such alternate (and
any alternate shall count towards the forming of a quorum for the purposes
of Board meetings if his appointor is not
present).
|
2.11 Shareholders
The
Shareholders undertake to the Company and each other, to the extent of their
respective rights from time to time, to vote as shareholders of the Company to
procure compliance by the Company and to procure compliance by the Board with
the terms of clause 2.
2.12 Quorum
The
quorum for meetings of the Board shall be as set out in the
Articles.
2.13 Remuneration
Committee
(A)
|
The
Board shall establish a
remuneration committee to whom the Board shall delegate the
responsibility of determining the remuneration of Directors and members of
the senior management of the Company (“Remuneration
Committee”).
|
(B)
|
The
Remuneration Committee comprise
a
minimum of three Directors, including the Investor Director
(if any).
|
7
2.14 Audit Committee
The Board
shall establish an audit committee (“Audit Committee”), comprising of a minimum of three Directors,
including the Investor Director (if any). The Audit Committee shall have general
responsibility for overseeing all accounting and auditing matters of the Company
and its Subsidiaries, including, among other things:
(A)
|
selecting
and monitoring the independence of the independent public accountants of
the Company and its
Subsidiaries;
|
(B)
|
approving
the scope and timing of the work to be performed and the compensation to
be paid to the independent auditors of the Company and its
Subsidiaries;
|
(C)
|
reviewing
with the Company’s management and the independent
auditors:
|
|
(1)
|
the
financial accounting and reporting principles appropriate for the Company
and its Subsidiaries;
|
|
(2)
|
the
policies and procedures concerning audits, accounting, internal controls
and financial controls; and
|
|
(3)
|
recommendations
to improve existing practices and the qualifications and work of the
internal auditing staff, if any;
|
(D)
|
reviewing
with the independent auditors the results of their audit and their report
including any changes in accounting principles and any significant
adjustments; and
|
(E)
|
meeting
with representatives of the internal audit staff to review the plan and
scope of work for the internal audit
staff.
|
The Audit
Committee shall have the power and authority to investigate any matter falling
within its jurisdiction (with the ability to retain special counsel to assist in
any such investigation) and may meet in executive session with the independent
auditors and representatives of the internal audit staff to review matters of
concern presented to the Audit Committee.
3.
Shareholder
Meetings
3.1 Quorum
The
quorum for meetings of members of the Company shall be as set out in the
Articles.
3.2 Registration of
Shareholders
The
Company undertakes to each Shareholder and the Shareholders undertake to each
other that they each will procure, to the extent of their respective rights from
time to time to vote as Shareholders and as Directors, so that no person is
registered as holder of any Shares (whether upon transfer of transmission or by
issue) except in accordance with this Agreement and the Articles.
3.3 Voting Rights
Each
holder of Preferred Shares shall be entitled to vote at members’ meetings on an
as-converted basis together with the holders of Ordinary
Shares.
8
3.4 Encumbrances
No holder
of Shares may transfer or otherwise dispose or pledge, grant an option over,
mortgage, charge or otherwise encumber any Share (or any beneficial interest
therein) other than in accordance with this Agreement and the
Articles.
4.
Information
4.1 Financial
information
The
Company and the Ordinary Shareholders undertake to the Investor that upon the
request of the Investor, the Company shall deliver to the Investor in such form
as agreed between the Company and the Investor or the Investor Director (if
any):
(A)
|
in
respect of the three financial quarters immediately following the date of
this Agreement, and within 45 days of the end of each such financial
quarter, the Group’s consolidated quarterly financial statements (profit
and loss statement, cash flow statement, balance sheets) and each Group
Company’s financial statements (profit and loss statement, cash flow
statement, balance sheets), together with a quarterly business
review;
|
(B)
|
audited
consolidated annual financial statements (project and loss statement, cash
flow statement, balance sheets) of the Group in accordance with IFRS and
individual annual financial statement (profit and loss statement, balance
sheets) of each Group Company as soon as the same is available but in any
event no later than 120 days after each year end;
and
|
(C)
|
within
4 calendar months after the end of each relevant financial year, copies of
the profit and loss accounts and balance sheets of each Group Company (and
for the Company on a consolidated basis), audited, in each case, by an
independent accounting firm of international
reputation.
|
4.2 Budget
The
Company and the Ordinary Shareholders undertake to the Investor that the Company
shall deliver to the Investor, as soon as it becomes available and not later
than 30 April each year, the Group’s annual budget in relation to the relevant
financial year in such form and detail as the Board shall reasonably
require.
4.3 Business of the
Group
The
Company shall keep the Investor informed of material matters relating to the
progress of the Group’s business to such extent and in such form and detail as
the Investor may from time to time reasonably require and shall supply to the
Investor such written particulars of any matters concerned with and arising out
of the activities of the Group as the Investor may from time to time reasonably
require.
4.4 Offer to acquire
The
Company shall give the Investor written notice of any offer which is proposed to
be made to all or any Shareholders to purchase from them any of their Shares
forthwith upon the Company becoming aware of the same.
9
4.5 Violation of laws
The
Company shall notify the Investor in writing promptly upon its becoming aware of
any violation by any Group Company of any applicable Laws which may materially
and adversely affect the business of any Group Company.
5. Reserved
Matters
The
Company (so far as it is lawful for it to do so) and the Ordinary Shareholders
each hereby undertake to the investor that they shall each use their respective
rights and powers to procure (so far as they are able) that none of the Reserved
Matters shall be transacted, carried out or approved by the Board or the Company
or the board of directors of any Group Company or any Group Company without the
prior written consent of the Investor Director (if any) or the Investor if no
Investor Director is appointed.
6. Pre-emption
on issues of New Securities
6.1 Pro-rata offer
Prior to
a Qualified IPO, before any New Securities are issued they shall first be
offered (“Original
Offer”) to each of the Shareholders pro rata to:
(A) the
number of Ordinary Shares held by such Shareholders; and
|
(B)
|
the
number of Ordinary Shares that the Investor would hold at such time if it
converted its holding of Preferred Shares in full into Ordinary Shares at
the then applicable conversion rate pursuant to Article 4A.2(C) of the
Articles (“Pro
Rata Entitlement”).
|
6.2 Original Offer
(A) The
Original Offer shall be made by notice specifying:
(1) the
number and class of New
Securities being offered; and
(2) the
price per New
Security being offered,
and
limiting a time (not being less than ten (10) Business Days or greater than
thirty (30) Business Days) (“Offer Period”) after such notice is deemed given within which
the offer, if not accepted by a written notice having been given to the Company,
will be deemed to be declined.
|
(B)
|
After
the expiration of the Offer Period, or on the receipt of an indication
from a Shareholder that it declines to accept the New
Securities offered or any of them, the Original Offer shall
be deemed withdrawn in respect of that
Shareholder.
|
6.3 Second Offer
|
(A)
|
If
the investor or any of the other Shareholders do not take up their Pro
Rata Entitlement so that there are excess New Securities (“Excess”) available for issue
under such offer, the Excess shall be offered to the Investor and the
other Shareholders who have taken up their Pro Rata Entitlement in
accordance with, their respective Pro Rata Entitlements and in accordance
with the provisions set out above in this clause 6 in relation to the
Original Offering (“Second
Offering”).
|
10
|
(B)
|
If
any Excess remains available after the Second Offering it shall not be
available for allotment and issue to any Shareholder or third party
without the consent of the Board.
|
6.4 Exceptions
This
clause 6 shall not apply:
|
(A)
|
upon
the conversion or reclassification of one class of Shares or other
securities of the Company already in issue into another class of Shares or
securities of the Company; or
|
|
(B)
|
exercise
of any anti-dilution rights by the Investor as set out under Article 4A.2
of the Articles; or
|
(C) upon
an Adjustment Event.
7. Pre-emptions
on transfers of Shares
7.1 Investor’s
consent
Each of
the Selling Shareholders undertakes to the Investor that it shall not, directly
or indirectly, sell, transfer, assign, pledge, charge or otherwise dispose of
any Share or any interest in any Share or any other interest in any Group
Company (whether debt or equity) or any of its rights, title, interests,
benefits or obligations under this Agreement except with the prior written
consent of the Investor. Any transfer of Shares that is made other than in
accordance with this clause 7.1 shall be void.
7.2 Restrictions on
disposal
No
Shareholder shall sell, transfer, assign, pledge, charge or otherwise dispose of
any Share or any interest in any Share except as permitted by this clause
7.
7.3 Transfer Notice
Subject
to clause 7.1, a Shareholder wishing to transfer Shares (“Seller”) shall give notice in writing (“Transfer Notice”) to each of the other Shareholders (“Ongoing
Shareholders”) specifying the
details of the proposed transfer, including the identity of the proposed
buyer(s), the number of Shares proposed to be transferred and the sale price for
the Shares.
7.4 Ongoing Shareholders’
response
Within 28
Business Days of the Transfer Notice having been given, each of the Ongoing
Shareholders shall give a notice to the
Seller
stating whether it wishes to purchase a proportion of the Shares
referred to in the Transfer Notice, which (i) the number of Ordinary Shares, or
(ii) the total number of Ordinary Shares that the Preferred Shareholder would
hold at such time if such Preferred Shares were converted in full into Ordinary
Shares at the then applicable conversion rate pursuant to Article 4A.2(C) of the
Articles (as the case may be) held by him bears to the total number of Fully
Diluted Ordinary Shares, at the sale price specified in the Transfer
Notice.
7.5 Sale to a third
party
If any of
the Ongoing Shareholders fail to give notice under clause 7.4:
11
|
(A)
|
the
Seller is entitled to transfer such portion of his Shares to the third
party buyer identified in the Transfer Notice at a price not less than the
price specified in the Transfer Notice;
and
|
|
(B)
|
the
Seller shall procure that any buyer of Shares that is not a party to this
Agreement shall, at completion of the acquisition, enter into a Deed of
Adherence.
|
7.6 Exceptions
(A)
|
The
provisions of this clause 7 shall not apply for an Adjustment
Event.
|
(B)
|
The
provisions of this clause 7 shall not apply for the conversion and/or
reclassification of one class of Shares or securities of the Company in
issue into another class of Shares or securities of the
Company.
|
(C)
|
The
provisions of this clause 7 shall not apply to any sale, transfer,
assignment, pledge, charge or otherwise disposal of any Share or any
interest in any Share by the Investor to any of its Affiliate, provided
that:
|
(1)
|
the
Investor shall give prior notice of such transfer to the other
Shareholders; and
|
(2)
|
if
the transferee of the Shares ceases to be an Affiliate of the Investor,
the Shares will be transferred back to the Investor unless the other
Shareholders consent in
writing.
|
8. Tag-along
8.1 Tag-along offer
|
(A)
|
Unless
the Investor otherwise consents in writing, no sale or transfer (directly
or indirectly) of the legal or beneficial interest in any Shares may be
made or validly registered, unless the Shareholder proposing the transfer
(“Proposing
Transferor”) shall have
procured that a written and irrevocable offer complying with the
provisions of clause 8.2 is made by the proposed transferee to the
Investor (“Tag-along
Offer”).
|
|
(B)
|
The
Proposing Transferor shall promptly notify the Directors of details of the
proposed sale and the identity of the proposed
transferee.
|
|
(C)
|
For
the avoidance of doubt, the provisions of clause 7 shall apply to
transfers referred to in this clause 8 and the provisions of clauses 7.3
and clause 7.4 shall be complied with prior to a Tag-along Offer being
made pursuant to this clause.
|
8.2 Terms of offer
The
Tag-along Offer shall:
(A)
|
offer
to acquire such percentage of the Investor’s Shares as is equal to the
percentage of the Proposing Transferor’s Shares being proposed for sale or
transfer by the Proposing
Transferor;
|
(B)
|
be
open for acceptance for a period of at least 15 Business Days following
the making of the offer;
|
12
|
(C)
|
be
on no less favourable terms than the terms of the sale of Shares by the
Proposing Transferee; and
|
|
(D)
|
be
completed at the same time and at the same price as the transaction
triggering the provisions of this clause
8.
|
8.3 Exceptions
The
provisions of this clause 8 shall not apply for an Adjustment
Event.
9.
Qualified
IPO
9.1 Timing
The
parties’ shall use their best efforts to effect a Qualified IPO as soon as
practicable and in any event within 2 years of the date of this Agreement. Each
of the Company and the Selling Shareholders agrees to keep each of the other
Shareholders informed of all and any developments which might lead to any
Qualified IPO.
9.2 Post-IPO sales of
Shares
It is
hereby agreed by the parties that, upon a Qualified IPO, the Investor and the
Selling Shareholders shall:
(A)
|
to
the extent required by:
|
(1)
|
the
Rules Governing the Listing of Securities on the Stock Exchange of Hong
Kong Limited (“Listing
Rules”); or
|
(2)
|
any
equivalent requirements of any Stock
Exchange,
|
retain
such
number of their Shares held at the time of the Qualified IPO for such period
after the Qualified IPO as is required by the Listing Rules or the rules and
requirements of the relevant stock exchange; and
(B)
|
have
regard to the recommendation of the Company’s underwriters on a Qualified
IPO in determining their respective sale of Shares upon the Qualified IPO
and shall make such determination with a view to ensuring the success of
the Qualified IPO, without prejudice to the Investor’s rights under clause
10.3.
|
9.3 Top-up
acquisition
Upon a
Qualified IPO, the Investor shall be entitled to purchase, at its option, such
number of the Ordinary Shares of the Company offered in the Qualified IPO at a
price per Share equal to the offering price in the Qualified IPO as may be
necessary in order to maintain its ownership percentage in the Company following
the Qualified IPO at the same percentage as it was immediately before the
completion of the Qualified IPO on a Fully Diluted basis.
9.4 Sale on IPO
(A)
|
The
parties expect that, on a Qualified IPO, the offering will comprise of
both new and existing Ordinary Shares. Upon a Qualified IPO and if and to
the extent that there is to be an offer for sale of existing Ordinary
Shares (“OFS Shares”), if any, each Shareholder shall have the
right (but not the obligation) to sell the number of Shares resulting from
the following formula (rounded down to the nearest whole
number):
|
13
A x
B/C
Where:
“A” is
the total number of OFS Shares (if any);
“B” is
the number of Shares held by that Shareholder on a Fully Diluted basis
immediately prior to the Qualified IPO; and
“C” is
the total number of Shares held by all Shareholders on a Fully Diluted basis
immediately prior to the Qualified IPO.
(B)
|
If
any Shareholder decides not to exercise its right to sell, then the
remaining Shareholders (including, for the avoidance of doubt, the
Investor) can take up the right not exercised, on a basis to be agreed
between all of the Shareholders that are exercising their right to sell,
and provided always that the Investor shall not sell more than 50 per cent
of the Shares it holds.
|
10. Rights
during Listing Process
10.1 Listing Process
In the
event that the Stock Exchange to which the Company submits its listing
application indicates in writing to the Company that for the purpose of
considering and approving the IPO, the parties to this Agreement should consider
amending or deleting any provision of this Agreement, the Company shall
immediately inform the parties of such written indication and, after the Company
has used its best endeavours in negotiating and in assisting the parties to
undertake negotiations with the Stock Exchange in relation to such amendments,
the parties shall act in good faith and use their reasonable commercial
endeavours to consult and to resolve such request of the Stock Exchange in a
manner that does not cause delay to the Listing Process.
10.2 Amendments
conditional
Any
amendments pursuant to clause 10.1 shall be conditional upon completion of the
IPO which shall be deemed to take place when the Shares are traded on the
relevant Stock Exchange. If completion of a proposed IPO does not occur within 6
months of the parties agreeing to any amendments to this Agreement in accordance
with clause 10.1, such amendments shall be void.
10.3 Approval of Qualified
IPO
(A)
|
The
venue of any IPO (including a Qualified IPO) other than the Main Board of
the Hong Kong Stock Exchange shall be subject to the Investors’ prior
written consent.
|
(B)
|
The
offering size of any IPO (including a Qualified IPO) shall be subject to
the Investor’s prior written consent if the number of newly issued Shares
available for subscription (including new Shares to be issued pursuant to
the exercise of the over-allotment option) would represent more than 25
per cent. of the total number of Shares in issue following the completion
of the IPO on a Fully Diluted
basis.
|
14
11. Registration
rights
The
Company undertakes that prior to any listing of any of its Shares in the United
States (or any other jurisdiction) where relevant, it shall prepare or procure
the preparation of a registration rights agreement (at the Company’s cost) in
customary form and shall enter into such agreement with the Investor granting
the Investor customary registration rights including (without limitation) demand
registration rights and piggy-back registration rights.
12. Representations
and Warranties of the Shareholders.
12.1 Each
Shareholder represents and warrants to the other Shareholders that:
(A)
|
such
Shareholder is duly organized, validly existing and in good standing under
the laws of the jurisdiction in which it is
organized;
|
(B)
|
the
execution, delivery and performance of this Agreement and the related
agreements to which it is a party by such Shareholder and performance of
its obligations hereunder and
thereunder:
|
(1)
|
are
within the organizational powers of such Shareholder, have been duly
authorized by all necessary action, and do not and will not contravene any
provision of law applicable to it or any contractual restriction binding
on or affecting it;
|
(2)
|
do
not require any other approval, authorization, license, exemption from,
consent of, or filing with, any governmental agency or authority, court or
any other third party except for those which have been duly obtained or
made and are in full force and effect, and are not, and will not be, in
contravention of the terms of such Shareholder’s organizational documents
or any amendment thereof;
|
(3)
|
will
not conflict with or result in any breach or contravention of or the
creation of any lien under any agreement, instrument or undertaking to
which such Shareholder is a party or by which it is bound;
and
|
(4)
|
are
and will be valid and legally binding obligations of such Shareholder
enforceable against such Shareholder in accordance with the terms hereof
or thereof, except as limited by bankruptcy, insolvency, reorganization or
similar laws relating to or affecting generally the enforcement of
creditors’ rights.
|
(C)
|
there
is no action, suit, arbitration, investigation, Tax audit or proceeding
pending, or to the actual knowledge of such Shareholder, threatened or
contemplated against such Shareholder before any court or administrative
agency nor is any substantial basis for any such litigation known to
exist, which either questions the legality, validity or propriety of this
Agreement or the transaction contemplated hereunder, or could materially
affect its ability to carry out its obligations under this Agreement;
and
|
(D)
|
such
Shareholder has complied and is in compliance in all material respects
with all applicable laws (including Tax laws), decrees and other similar
documents and instruments of all courts and governmental authorities,
bureaus and agencies, domestic and foreign, non-compliance with which
could have a material adverse effect on the business, operations,
financial condition or properties of such Shareholder, its Affiliates or
the Company or on the ability of such Shareholder to perform its
obligations under this
Agreement.
|
15
13. FCPA
warranty and undertaking
13.1 Warranties and
representations
(A)
|
The
Company warrants and represents to the Investor that none of the Company
nor any of its Subsidiaries or any director, officer, agent, employee, or
any other person acting for or on behalf of the foregoing (individually
and collectively, a “Company
Affiliate”), has violated the
U.S. Foreign Corrupt Practices Act or any other applicable anti-bribery or
anti-corruption laws, nor has any Company Affiliate offered, paid,
promised to pay, or authorized the payment of any money, or offered,
given, promised to give, or authorized the giving of anything of value, to
any officer, employee or any other person acting in an official capacity
for any Government Entity, as defined below, to any political party or
official thereof or to any candidate for political office (individually
and collectively, a “Government
Official”) or to any person
under circumstances where such Company Affiliate knew or was aware of a
high probability that all or a portion of such money or thing of value
would be offered, given or promised, directly or indirectly, to any
Government Official, for the purpose
of:
|
(1)
|
(a)
|
influencing
any act or decision of such Government Official in his official
capacity,
|
|
(b)
|
inducing
such Government Official to do or omit to do any act in relation to his
lawful duty,
|
(c)
|
securing
any improper advantage, or
|
|
(d)
|
inducing
such Government Official to influence or affect any act or decision of any
Government Entity, or
|
(2)
|
in
order to assist the Company or any Subsidiary in obtaining or retaining
business for or with, or directing business to the Company or its
subsidiary.
|
(B)
|
“Government
Entity” as used in the clause
13.1(A) above means any government or any department, agency or
instrumentality thereof, including any entity or enterprise owned or
controlled by a government, or a public international
organization.
|
13.2
|
The
Company undertakes and covenants with the Investor that it will ensure
that the warranties and representations set out in clause 13.1 remain
true, accurate and not misleading at all times after the Completion for so
long as the Investor or the Investor’s Affiliate remains a
shareholder.
|
14. Tax
matters
14.1
|
The
Company will make reasonable inquiries and report to the Investor as to
whether it has currently or at the end of each year five or fewer persons
who are “United
States shareholders” that collectively own more than fifty percent
of the Company shares. For this purpose, a “United States
shareholder” is a direct or
indirect holder of at least ten percent of the Company shares that
is:
|
|
(A)
|
a
United States citizen; or
|
16
|
(B)
|
an
individual who is a lawful permanent resident of the United States or was
present in the United States for more than 183 days in the aggregate in
the current calendar year and the two immediately preceding calendar
years; or
|
(C)
|
an
entity that is organized in the United States;
or
|
|
(D)
|
an
estate whose income is subject to United States federal income tax or a
trust subject to primary supervision in the Unites States where a United
States person is authorized to control ail substantial decisions of the
trust.
|
14.2
|
The
Company and any of its Subsidiaries have not made any US tax elections and
will not make any United States tax elections in the future without the
prior written consent of the
Investor.
|
14.3
|
The
Company and its Subsidiaries shall reasonably assist the Investor and the
Affiliates of the Investor in complying with their obligations under the
United States tax laws. Such assistance shall include: (i) the Company
permitting the Investor and any of its advisors or representatives to
examine, inspect and copy the permanent books of account, records and
other documents of the Company and each of its Subsidiaries; and (ii) if
the Investor determines in its sole opinion that it is required, each year
the Company and each applicable Subsidiary shall provide to the Investor a
statement signed by the Company or the respective Subsidiary (or an
authorized representative of the Company or the respective Subsidiary)
(the “PFIC
Annual Information Statement”)
stating:
|
(A)
|
the
dates to which the statement
applies,
|
(B)
|
that
the Investor has been and will be permitted to examine, inspect and copy
the books of account, records and such other documents of the Company and
each applicable Subsidiary as are necessary for the Investor or the
Investor’s advisers to calculate the amount of the Company’s or each
applicable Subsidiary’s ordinary earnings and net capital gain according
to United States federal income tax accounting principles and the
Investor’s pro rata shares
thereof,
|
(C)
|
any
distributions made by the Company or applicable Subsidiary during such
period, and
|
(D)
|
any
other information about the income and gains of the Company and each
applicable Subsidiary which the Investor requires to complete its United
States tax returns.
|
14.4
|
The
Company and all the Subsidiaries will file all Tax Returns and make all
Tax payments in a timely manner.
|
14.5
|
The
Company and all the Subsidiaries will carry out all transactions on an
arms-length basis.
|
15.
Adherence
and Assignment
15.1
Binding
effect
Subject
to this clause 14, this Agreement shall be binding upon and enure for the
benefit of the successors and assignees of the parties.
17
15.2 Successors and
assigns
Except
for an assignment by the Investor to any of its Affiliates, no party or their
respective successors and assignees shall be entitled to assign its rights or
obligations under this Agreement without the prior written consent of the other
parties.
15.3 Adherence
No
transfers of Shares (including, without limitation, upon exercise of options) or
issues or allotments of new Shares (including, without limitation, upon exercise
of options) or assignment under clause 7.1 shall take place unless the
transferee or allottee or assignee either is a party to this Agreement or has
entered into the Deed of Adherence.
16. Announcement
16.1 Disclosure
Save as
required by any applicable laws or regulations or in relation to information
which is publicly available (other than by reason of any wrongful disclosure of
the same), no party shall, save with the prior written consent of the other
parties, make any announcement or otherwise disclose or divulge any information,
concerning the Investors’ involvement with, or interest in, the Company or the
Group including (without limitation) any of the terms set forth in this
Agreement, or use the name of Xxxxxxx Xxxxx Group Inc., or any Affiliate of the
Investor without obtaining in each instance the prior written consent of the
Investor.
16.2 Survival of
termination
The
restrictions contained in this clause 16 shall survive the termination of this
Agreement and continue without limit of time.
17. Compliance
17.1 Compliance by
Company
The
Company undertakes to each Shareholder that it will observe and perform the
provisions of this Agreement and the documents entered into pursuant to this
Agreement.
17.2 Compliance by Ordinary
Shareholders
Each of
the Ordinary Shareholders shall, in so far as it lies within their power for the
time being and are lawfully able and subject to any fiduciary duties if
applicable, use reasonable endeavours to ensure compliance by the Company with
its obligations and other commitments under this Agreement and the documents
entered into pursuant to this Agreement, and the Articles and to inform the
Investor forthwith on their becoming aware of any breach of the
same.
18. Confidentiality
18.1
Confidentiality
obligations
During
the term of this Agreement and after termination or expiration of this Agreement
for any reason whatsoever, the Receiving Party shall:
|
(A)
|
keep
the Confidential Information
confidential;
|
18
|
(B)
|
not
disclose the Confidential Information to any other person other than with
the prior written consent of the Disclosing Party or in accordance with
clauses 18.2 or 18.4 below;
|
|
(C)
|
not
issue any press release with respect to any arrangement under this
Agreement, the Share Purchase Agreement and the Subscription Agreement,
except with the prior written consent of the Company and of the Investor;
and
|
|
(D)
|
not
use the Confidential Information for any purpose other than the
performance of its obligations under this Agreement and in connection with
any services being properly performed as a director, officer or employee
of any of the Group Companies.
|
18.2 Permitted
disclosure
During
the term of this Agreement, the Receiving Party and/or its affiliates may
disclose the Confidential Information to the following persons:
(A)
|
if
the Receiving Party is the Company, Selling Shareholders or the other
Shareholders, to each of its directors, employees, financial advisers or
legal advisers and persons involved in the Listing
Process;
|
(B)
|
if
the Receiving Party is the Investor or its affiliates, to its affiliates
and its and their respective employees, officers, directors, agents and
advisors, fund managers and investors, regulatory authorities or otherwise
as required by law or in connection with legal proceedings;
or
|
(C)
|
its
professional advisers provided that such disclosure has a legitimate
business purpose.
|
18.3 Recipients of Confidential
Information
The
Receiving Party shall use its reasonable endeavours to procure that each
recipient of the Confidential Information (as permitted under clause 18.2) is
made aware of, and complies with, all the Receiving Party’s obligations of
confidentiality under this Agreement as if the recipient was itself a party to
this Agreement.
18.4 Exceptions
The
obligations contained in clauses 18.1 to 18.3 shall not apply to any
Confidential Information which:
(A)
|
is
at the date of this Agreement in, or at any time after the date of this
Agreement comes into, the public domain other than through breach of this
Agreement by a Receiving Party or any subsequent recipient (as permitted
under clause 18.2);
|
(B)
|
can
be shown by the Receiving Party and/or its affiliates to the reasonable
satisfaction of the Disclosing Party to have been known to the Receiving
Party prior to it being disclosed by the Disclosing Party to the Receiving
Party;
|
(C)
|
subsequently
comes lawfully into the possession of the Receiving Party and/or its
affiliates from a third
party;
|
(D)
|
is
required for the Receiving Party and/or its affiliates to be disclosed
according to any applicable laws or regulations or the requirements of any
judicial or regulatory body or authority which it is subject to;
or
|
19
|
(E)
|
is
required to be disclosed by a party and/or its affiliates in order to
enable it to enforce its rights under this
Agreement.
|
19. Supremacy
In the
event of any conflict between the terms of this Agreement and the Articles then
or the constitutional documents of any other Group Company in effect at such
time, the parties agree that (as amongst themselves but not so as to amend the
Articles), the provisions of this Agreement shall prevail and the Shareholders
undertake to each other to take all necessary actions to procure that the
Articles or such constitutional documents of such other Group Company are
amended to ensure that the provisions of this Agreement are given full
effect.
20. Termination
This
Agreement shall expire and (save for accrued rights and obligations) be of no
further force or effect upon the earlier of:
(A)
|
in
respect of any party (other than the Company), that party ceasing to hold
any Shares; or
|
(B)
|
completion
of a Share Sale or a Qualified IPO;
or
|
(C)
|
by
the agreement in writing of the
Investor.
|
21. General
21.1 No partnership or
agency
Nothing
contained in this Agreement shall constitute or be deemed to constitute a
partnership between the parties or any of them and no party shall hold himself
out as an agent for any other party for any purpose save with the prior written
consent of such other party. In addition, unless otherwise agreed in writing
between the parties, neither of them shall enter into any contracts or
commitments with any third party as agent for any Group Company or for the other
party nor shall either party describe itself as such an agent or in any way hold
itself out as being such an agent.
21.2 Entire Agreement
The
parties agree that this Agreement, the Share Purchase Agreement and the
Subscription Agreement together represent the entire agreement between the
parties in relation to the matters the subject matter hereof and shall replace
and supersede any previous agreement or understanding between all or any of the
parties in relation to all or any such matters.
21.3 Severability
The
provisions contained in each clause and/or sub-clause of this Agreement shall be
enforceable independently of the others and the invalidity of any one provision
shall not affect the validity of the others. The rights of the parties under
this Agreement are independent, cumulative and without prejudice to all other
rights available to them unless otherwise specifically provided for under this
Agreement and the exercise or non-exercise of any such rights shall not
prejudice or constitute a waiver of any other rights of the Investors whether
under this Agreement or otherwise unless otherwise specifically provided for
under this Agreement.
20
21.4 Further
assurances
Each
Shareholder shall procure the passing of such resolutions, execute such
documents and waivers and generally do everything further reasonably required by
the Investor effectively to comply with their obligations under this Agreement
and to vest the full benefit of this Agreement in the Investor.
21.5
Costs
and expenses
Without
prejudice to clause 21.4, each party shall pay its own costs of, and incidental
to, the negotiation, preparation, execution, performance and implementation of
this Agreement and each document referred to in it.
21.6 Counterparts
This
Agreement may be executed in any number of counterparts, each of which, when
executed, shall be an original, and all the counterparts together shall
constitute one and the same instrument. This Agreement shall not be
effective until each party has executed a counterpart.
21.7 Variation
No
variation of this Agreement shall be binding on any party unless and to the
extent that the same is recorded in a written agreement duly entered into by all
parties.
22. Waiver
Failure
by any party at any time or times to require performance of any provision of
this Agreement shall in no manner affect his right to enforce such provision at
a later time. No waiver by any party of any condition or the breach of any term,
covenant, representation or warranty contained in this Agreement (whether by
conduct or otherwise) shall be deemed to be, or construed as, a further or
continuing waiver of any such condition or breach or a waiver of any other
condition or be deemed to be, or construed as, the breach of, or a waiver of,
any other term, covenant, representation or warranty contained in this
Agreement.
23. Notices
23.1 Form
Any
notice or other communication under or in connection with this Agreement shall
be in writing, in the English language and delivered personally or sent by post
pre-paid recorded delivery (and air mail if overseas) or by fax, to the party
due to receive the notice at its address or fax number set out in schedule 1 of
this Agreement, or such other address or fax number as any party may specify by
notice in writing to the others.
23.2 Receipt
In the
absence of evidence of earlier receipt, any notice or other communications is
deemed given:
(A)
|
if
delivered personally, when the person delivering it obtains the signature
of receipt from a person at the relevant
address;
|
(B)
|
if
sent by mail other than air mail, two business days after posting it;
and
|
(C)
|
if
sent by air mail, six business days after posting it;
and
|
21
(D)
|
if
sent by fax, when despatched subject to confirmation of uninterrupted
transmission by a transmission report, provided that any notice despatched
by fax after 17:00 hours Hong Kong time (at the place where such fax is to
be received) on any day shall be deemed to have been received at 08:00
hours on the next business
day.
|
23.3 Service
In
proving service of any notice it shall be sufficient to prove:
(A)
|
in
the case of a notice sent by post that such notice was properly addressed,
stamped and placed in the
post;
|
(B)
|
in
the case of a notice personally delivered that it was declined to or left
at the specified address;
|
(C)
|
in
the case of a notice sent by fax that it was duly despatched to the
specified number as confirmed by a transmission report;
and
|
(D)
|
in
the case of a notice sent by air courier that it was delivered to a
representative of the
courier.
|
24. Information
to Investor
The
Company shall keep the Investor informed, on a current basis, of any events,
discussions, notices or changes with respect to any criminal or regulatory
investigation or action involving the Company or any of its subsidiaries, so
that the Investor will have the opportunity to take appropriate steps to avoid
or mitigate any regulatory consequences to them that might arise from such
criminal or regulatory investigation or action and Company and/or the relevant
Shareholders shall reasonably cooperate with the Investor, their members and
their respective Affiliates in an effort to avoid or mitigate any cost or
regulatory consequences that might arise from such investigation or action
(including by reviewing written submissions in advance, attending meetings with
authorities, coordinating and providing assistance in meeting with regulators
and, if requested by the Investor, making a public announcement of such
matters).
25. Law and
Jurisdiction
25.1 Hong Kong Law
This
Agreement shall be governed by, and construed in accordance with, Hong Kong
law.
25.2 Dispute
Resolution
(A)
|
Any
dispute, controversy or claim arising out of or relating to this
Agreement, or the breach, termination or invalidity thereof, shall be
settled by arbitration in Hong Kong under the UNCITRAL Arbitration Rules
in accordance with the Hong Kong International Arbitration Centre (HKIAC)
Procedures for the Administration of International Arbitration in force at
the date of this Agreement. The HKIAC shall be the arbitration
commission.
|
(B)
|
The
seat of the arbitration shall be Hong Kong and the arbitration shall take
place at the HKIAC. There shall be three arbitrators, one of whom shall be
nominated by the Investor, one of whom shall be jointly nominated by the
other parties to the arbitration and one of whom shall be nominated by the
HKIAC, who shall act as the chairman of the tribunal. The award shall be
given by majority decision. If there be no majority, the award shall be
made by the Chairman of the tribunal
alone.
|
22
(C)
|
The
language to be used in the arbitral proceedings shall be
English.
|
(D)
|
By
agreeing to arbitration pursuant to this clause, the parties waive
irrevocably their right to any form of appeal, review or recourse to any
state court of other judicial authority, insofar as such waiver may
validly be made.
|
(E)
|
Any
party shall have the right to seek interim injunctive relief from a court
of competent jurisdiction, both before and after the arbitrators have been
appointed, at any time up until the arbitrators have made their final
award.
|
AS WITNESS the hands
of the duly authorised representatives of the parties on the date first before
written.
23
Company
|
||
SIGNED by LIN SHUIPAN
duly authorised for and on
behalf of
XDLONG INTERNATIONAL
COMPANY LIMITED
|
)
)
)
)
)
|
![]() |
Ordinary Shareholders
|
||
SIGNED by LIN SHUIPAN
|
)
|
![]() |
SIGNED by Xxxx Xxxxx
duly authorised for and on
behalf of
TIANCHENG INT’L INVESTMENT
GROUP LIMITED
|
)
)
)
)
)
|
![]() |
SIGNED by Xxxxx Xxx Sum
duly authorised for and on
behalf of
XX XXXXX GROUP LIMITED
|
)
)
)
)
|
![]() |
SIGNED by Liu Zeng Hong
duly authorised for and on
behalf of
EAGLE RISE
INVESTMENTS LIMITED
|
)
)
)
)
)
|
|
SIGNED by Xx Xxxxx Xxx
duly authorised for and on
behalf of
RICHWISE INTERNATIONAL
INVESTMENT GROUP LIMITED
|
)
)
)
)
)
|
![]() |
30
Company
|
||
SIGNED by LIN SHUIPAN
duly
authorised for and on
behalf
of
XDLONG
INTERNATIONAL
COMPANY
LIMITED
|
)
)
)
)
)
|
|
Ordinary
Shareholders
|
||
SIGNED by LIN
SHUIPAN
|
)
|
|
SIGNED by Xxxx
Xxxxx
duly
authorised for and on
behalf
of
TIANCHENG
INT’L INVESTMENT
GROUP
LIMITED
|
)
)
)
)
)
|
|
SIGNED by Xxxxx Xxx
Sum
duly
authorised for and on
behalf
of
XX
XXXXX GROUP LIMITED
|
)
)
)
)
|
|
SIGNED by Liu Zeng
Hong
duly
authorised for and on
behalf
of
EAGLE
RISE
INVESTMENTS
LIMITED
|
)
)
)
)
)
|
![]() |
SIGNED by Xx Xxxxx
Xxx
duly
authorised for and on
behalf
of
RICHWISE
INTERNATIONAL
INVESTMENT
GROUP LIMITED
|
)
)
)
)
)
|
30
Investor
|
||
SIGNED by
duly
authorised for and on
behalf
of
ELEVATECH
LIMITED
|
)
)
)
)
|
![]() |
31